# RougeTx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rougetx-b-v

- Industry: Biotechnology
- Headquarters: Naarden, Netherlands
- Website: www.rougetx.com
- Total disclosed funding: $58M
- Latest round: Series A (Oct 6, 2026)
- Investors on record: 9

## About

Founded in 2024 and based in Naarden, Netherlands, RougeTx is a biotechnology company that develops small-molecule therapies that target pericytes, specialized cells involved in maintaining blood vessel stability and function for rare vascular disorder.

## Funding rounds

- Series A, Oct 6, 2026, $58M — BioGeneration Ventures, Vesalius Biocapital, Kurma Partners, Epidarex Capital, ROM Utrecht Region, Angelini Ventures, p53, Aurea Group, Kerna Ventures

## Investors

- BioGeneration Ventures (https://capitalatlas.ai/funds/biogeneration-ventures) — Series A
- Vesalius Biocapital (https://capitalatlas.ai/funds/vesalius-biocapital) — Series A
- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Series A
- Epidarex Capital (https://capitalatlas.ai/funds/epidarex-capital) — Series A
- ROM Utrecht Region (https://capitalatlas.ai/funds/rom-utrecht-region) — Series A
- Angelini Ventures (https://capitalatlas.ai/funds/angelini-ventures) — Series A
- p53 (https://capitalatlas.ai/funds/p53) — Series A
- Aurea Group (https://capitalatlas.ai/funds/aurea-group) — Series A
- Kerna Ventures — Series A